Accession Number: | 0001209191-19-057604 |
Date: | 2019-11-19 |
Issuer: | CRISPR THERAPEUTICS AG (CRSP) |
Original Submission Date: |
NOVAK RODGER
C/O CRISPR THERAPEUTICS, INC.
610 MAIN STREET
CAMBRIDGE, MA 02139
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON SHARES | 2019-11-19 | M | 33,618 | a | $14.43 | 33,618 | direct | ||
COMMON SHARES | 2019-11-19 | S | 33,618 | d | $70.00 | 0 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 14.43 | 2019-11-19 | deemed execution date | M | 33,618 (d) | 2024-01-15 | common shares 33,618 | $14.43 | 236,382 | direct |
ID | footnote |
---|---|
f1 | the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person. |
f2 | 270,000 options to purchase common shares were granted on june 15, 2017 and originally vested in 48 equal monthly installments commencing upon the grant date. pursuant to dr. novak's amended and restated employment agreement with the company, subject to his continued employment, beginning november 30, 2018, the remaining unvested options from this grant vest in equal monthly installments at the rate of 50% of the amounts originally scheduled to vest on any one vesting date, and the original vesting schedule was extended to reflect the amended schedule. |